Patents by Inventor Nathaniel Lallatin

Nathaniel Lallatin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
    Patent number: 7837998
    Abstract: Monoclonal antibodies to thymidine kinase 1 are disclosed which are useful in methods of detecting, diagnosing, and treating cancer.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: November 23, 2010
    Inventors: Nathaniel Lallatin, Kim L. O'Neill
  • Anti-viral activity of an anti-thymidine kinase monoclonal antibody
    Patent number: 7311906
    Abstract: Monoclonal antibodies to thymidine kinase 1 are disclosed which are useful in methods of detecting, diagnosing, and treating viral infection.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: December 25, 2007
    Assignee: Brigham Young University
    Inventors: Nathaniel Lallatin, Kim L. O'Neill
  • Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
    Publication number: 20060039914
    Abstract: Monoclonal antibodies to thymidine kinase 1 are disclosed which are useful in methods of detecting, diagnosing, and treating cancer.
    Type: Application
    Filed: May 20, 2005
    Publication date: February 23, 2006
    Inventors: Nathaniel Lallatin, Kim ONeill
  • Anti-viral activity of an anti-thymidine kinase monoclonal antibody
    Publication number: 20060024311
    Abstract: Monoclonal antibodies to thymidine kinase 1 are disclosed which are useful in methods of detecting, diagnosing, and treating viral infection.
    Type: Application
    Filed: April 28, 2005
    Publication date: February 2, 2006
    Inventors: Nathaniel Lallatin, Kim O'Neill